Henri M. Garrison-Desany

Henri M. Garrison-Desany

Auto-generated profile, based on publicly available information

Henri M. Garrison-Desany

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
HGHenri M. Garrison-Desany
Henri M. Garrison-Desany
EWEmily Wilson
Emily Wilson
MMMelinda Munos
Melinda Munos
TSTalata Sawadogo-Lewis
Talata Sawadogo-Lewis
AMAbdoulaye Maïga
Abdoulaye Maïga
RMRosemary Morgan
Rosemary Morgan
Background: Gender is a crucial consideration of human rights that impacts many priority maternal health outcomes. However, gender is often only reported in relation to sex-disaggregated data in health coverage surveys. Few coverage surveys to date have integrated a more expansive set of gender-related questions and indicators, especially in low- to middle-income countries that have high levels of reported gender inequality. Using various gender-sensitive indicators, we investigated the role of gender power relations within households on women’s health outcomes in Simiyu region, Tanzania. Methods: We assessed 34 questions around gender dynamics reported by men and women against 18 women’s health outcomes. We created directed acyclic graphs (DAGs) to theorize the relationship between indicators, outcomes, and sociodemographic covariates. We grouped gender variables into four categories using an established gender framework: (1) women’s decision-making, (2) household labor-sharing, (3) women’s resource access, and (4) norms/beliefs. Gender indicators that were most proximate to the health outcomes in the DAG were tested using multivariate logistic regression, adjusting for sociodemographic factors. Results: The overall percent agreement of gender-related indicators within couples was 68.6%. The lowest couple concordance was a woman’s autonomy to decide to see family/friends without permission from her husband/partner (40.1%). A number of relationships between gender-related indicators and health outcomes emerged: questions from the decision-making domain were found to play a large role in women’s health outcomes, and condoms and contraceptive outcomes had the most robust relationship with gender indicators. Women who reported being able to make their own health decisions were 1.57 times (95% CI: 1.12, 2.20) more likely to use condoms. Women who reported that they decide how many children they had also reported high contraception use (OR: 1.79, 95% CI: 1.34, 2.39). Seeking care at the health facility was also associated with women’s autonomy for making major household purchases (OR: 1.35, 95% CI: 1.13, 1.62). Conclusions: The association between decision-making and other gender domains with women’s health outcomes highlights the need for heightened attention to gender dimensions of intervention coverage in maternal health. Future studies should integrate and analyze gender-sensitive questions within coverage surveys.

11 March 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
HGHenri M. Garrison-Desany
Henri M. Garrison-Desany
XHXiumei Hong
Xiumei Hong
BMBrion S. Maher
Brion S. Maher
TBTerri H. Beaty
Terri H. Beaty
GWGuoying Wang
Guoying Wang
CLChristine Ladd-Acosta
Christine Ladd-Acosta
Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental condition diagnosed in approximately 1 in 10 children as of 2016.1 Attention-deficit/hyperactivity disorder has numerous known sequelae that persist from childhood to adulthood, including increased risk of other mental health disorders,2-5 lower employment and educational attainment,6,7 and higher all-cause8,9 and suicide-specific mortality,10 despite recent improvements in treatment strategies. Identification of modifiable risk factors in the prenatal and early-life periods may provide new avenues for prevention efforts. It may also improve early detection of individuals at high risk to complement existing treatment, which could ultimately address disabilities associated with ADHD and improve long-term health outcomes.

19 October 2021 in Scandinavian Journal of Public Health
Verified
Journal Article
Open access
PDF file
Aude RichardAude Richard
Aude Richard
AWAnia Wisniak
Ania Wisniak
JPJavier Perez-Saez
Javier Perez-Saez
HGHenri Garrison-Desany
Henri Garrison-Desany
DPDusan Petrovic
Dusan Petrovic
VRViviane Richard
Viviane Richard
Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Switzerland, as well as risk factors for infection and symptoms associated with IgG seropositivity. Methods: Between April and June 2020, former participants of a representative survey of the 20–74-year-old population of canton Geneva were invited to participate in the study, along with household members aged over 5 years. Blood samples were tested for anti-SARS-CoV-2 immunoglobulin G. Questionnaires were self-administered. We estimated seroprevalence with a Bayesian model accounting for test performance and sampling design. Results: We included 8344 participants, with an overall adjusted seroprevalence of 7.8% (95% credible interval 6.8–8.9). Seroprevalence was highest among 18–49 year-olds (9.5%), and lowest in 5–9-year-old children (4.3%) and individuals >65 years (4.7-5.4%). Odds of seropositivity were significantly reduced for female retirees and unemployed men compared to employed individuals, and smokers compared to non-smokers. We found no significant association between occupation, level of education, neighborhood income and the risk of being seropositive. The symptom most strongly associated with seropositivity was anosmia/dysgeusia. Conclusions: Anti-SARS-CoV-2 population seroprevalence remained low after the first wave in Geneva. Socioeconomic factors were not associated with seropositivity in this sample. The elderly, young children and smokers were less frequently seropositive, although it is not clear how biology and behaviours shape these differences.

21 September 2022 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
TATyler Adamson
Tyler Adamson
LLLanair Lett
Lanair Lett
JGJennifer Glick
Jennifer Glick
HGHenri M Garrison-Desany
Henri M Garrison-Desany
ARArjee Restar
Arjee Restar
Objectives To characterise the extent to which the levels of violence and discrimination against lesbian, gay, bisexual, transgender and queer (LGBTQ+) people have changed amid COVID-19. Design Cross-sectional, secondary analysis. Setting 79 countries. Participants All adults (aged ≥18 years) who used the Hornet social networking application and provided consent to participate. Main outcome measure The main outcome was whether individuals have experienced less, or the same or more levels of discrimination and violence from specific groups (eg, police and/or military, government representatives, healthcare providers). Results 7758 LGBTQ+ individuals provided responses regarding levels of discrimination and violence. A majority identified as gay (78.95%) and cisgender (94.8%). Identifying as gay or queer was associated with increased odds of experiencing the same or more discrimination from government representatives (OR=1.89, 95% CI 1.04 to 3.45, p=0.045) and healthcare providers (OR=2.51, 95% CI 0.86 to 7.36, p=0.002) due to COVID-19. Being a member of an ethnic minority was associated with increased odds of discrimination and violence from police and/or military (OR=1.32, 95% CI 1.13 to 1.54, p=0.0) and government representatives (OR=1.47, 95% CI 1.29 to 1.69, p=0.0) since COVID-19. Having a disability was significantly associated with increased odds of violence and discrimination from police and/or military (OR=1.38, 95% CI 1.15 to 1.71, p=0.0) and healthcare providers (OR=1.35, 95% CI 1.07 to 1.71, p=0.009). Conclusions Our results suggest that despite the upending nature of the COVID-19 pandemic, around the world, government representatives, policymakers and healthcare providers continue to perpetuate systemic discrimination and fail to prevent violence against members of the LGBTQ+ community.

13 August 2020 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
HGH. M. Garrison-Desany
H. M. Garrison-Desany
MLM. E. Lasater
M. E. Lasater
NLN. P. Luitel
N. P. Luitel
DRD. Rimal
D. Rimal
DPD. Pun
D. Pun
PSP. J. Surkan
P. J. Surkan

1 February 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Pamela J. SurkanPamela J. Surkan
Pamela J. Surkan
HGHenri M. Garrison-Desany
Henri M. Garrison-Desany
DRDamodar Rimal
Damodar Rimal
NLNagendra P. Luitel
Nagendra P. Luitel
YKYoona Kim
Yoona Kim
SMSarah M. Murray
Sarah M. Murray